The Global Newborn Screening and Genetic Services Market was valued at USD 1.35 Billion in 2024 and is projected to reach USD 2.84 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period (2025–2032). This growth is being driven by increasing awareness of genetic disorders, government mandates for newborn screening programs, and the accelerating adoption of next-generation sequencing (NGS) solutions across public health and clinical settings.

As the healthcare industry transforms toward preventive care and precision genomics, the spotlight is on the key providers who are driving innovation, accuracy, and accessible screening pathways. In this blog, we profile the Top 10 Companies in the Newborn Screening and Genetic Services Industry—a mix of diagnostic giants, biotech innovators, and screening specialists shaping the future of global neonatal health.

---

🔟 1. Trivitron Healthcare

Headquarters: Chennai, India
Key Offering: Newborn screening analyzers, hearing screening devices, tandem mass spectrometry systems

Trivitron Healthcare is a prominent player in emerging markets, delivering affordable and reliable newborn screening solutions tailored for high-volume public health programs. The company serves hospitals, clinics, and government initiatives in Asia and Africa, focusing on comprehensive panels for metabolic, endocrine, and hearing disorders. With a strong emphasis on cost-effective technology, Trivitron enables widespread access to early detection in resource-limited settings, supporting national screening mandates through robust, easy-to-use equipment.

Screening Innovations:

• Development of indigenous tandem MS systems for metabolic screening

• Partnerships with governments for large-scale screening rollout

• Expansion of point-of-care hearing and CCHD devices

Download FREE Sample Report: Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

9️⃣ 2. AB Sciex LLC

Headquarters: Framingham, Massachusetts, USA
Key Offering: Mass spectrometry instruments, newborn screening assays

AB Sciex, a leader in analytical instrumentation, provides high-precision mass spectrometry solutions critical for confirmatory newborn screening. Their systems are used in reference labs worldwide to detect rare metabolic disorders from dried blood spots with exceptional sensitivity. The company’s technology supports expanded screening panels, helping public health agencies achieve accurate diagnostics at scale while integrating seamlessly with laboratory workflows.

Screening Innovations:

• Advanced triple quadrupole systems for multi-analyte detection

• Software enhancements for rapid data analysis and reporting

• Collaborations with screening labs for method validation

---

8️⃣ 3. Waters Corporation

Headquarters: Milford, Massachusetts, USA
Key Offering: LC-MS systems, chromatography solutions for genetic testing

Waters Corporation excels in liquid chromatography-mass spectrometry (LC-MS) technologies that underpin newborn screening for complex biomarkers. Deployed in clinical labs globally, their instruments enable precise quantification of amino acids and acylcarnitines, essential for identifying inborn errors of metabolism. Waters continues to innovate in workflow automation, reducing turnaround times and enhancing reliability in high-throughput environments.

Screening Innovations:

• UPLC-MS/MS platforms optimized for neonatal samples

• Integration of AI for peak identification and quality control

• Global support for newborn screening reference materials

---

7️⃣ 4. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Diagnostic imaging, pulse oximetry for CCHD screening

GE Healthcare contributes to newborn screening through advanced imaging and monitoring devices used in neonatal intensive care units. Their pulse oximetry and echocardiography tools aid in early detection of critical congenital heart defects, complementing genetic tests. With a focus on integrated healthcare solutions, GE supports hospitals in implementing comprehensive screening protocols from birth to follow-up care.

Screening Innovations:

• Portable pulse oximeters for bedside CCHD screening

• AI-enabled ultrasound for rapid heart defect visualization

• Digital platforms for screening data management

Download FREE Sample Report: Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

6️⃣ 5. Agilent Technologies

Headquarters: Santa Clara, California, USA
Key Offering: GC/MS and LC/MS for newborn metabolic screening

Agilent Technologies offers robust analytical instruments vital for tandem mass spectrometry in newborn screening labs. Their solutions detect over 50 metabolic disorders efficiently, supporting state-mandated programs across North America and Europe. Agilent’s commitment to R&D ensures continuous improvements in resolution and throughput, making complex genetic analyses more feasible for routine use.

Screening Innovations:

• High-resolution mass specs for expanded disorder panels

• Automated sample prep kits for blood spot analysis

• Cloud-based informatics for lab-to-lab data sharing

---

5️⃣ 6. Masimo Corporation

Headquarters: Irvine, California, USA
Key Offering: Pulse oximetry devices for CCHD screening

Masimo Corporation leads in non-invasive screening with SET pulse oximetry technology recommended by health authorities for detecting critical congenital heart disease. Their devices provide accurate oxygen saturation readings in newborns, integrated into hospital protocols worldwide. Masimo’s innovations extend to wireless monitoring, facilitating seamless screening in diverse clinical settings.

Screening Innovations:

• Rainbow SET technology for motion-tolerant readings

• Deployment in over 100 countries for heart screening

• Integration with EMR for automated flagging

---

4️⃣ 7. Natus Medical Incorporated

Headquarters: Middleton, Wisconsin, USA
Key Offering: Hearing screening systems, ALGO newborn hearing screener

Natus Medical specializes in newborn audiology screening, with devices like the ALGO platform screening millions of infants annually. Their otoacoustic emission and auditory brainstem response tests ensure early hearing loss detection, critical for language development. Natus supports global programs with portable, user-friendly solutions for maternity wards.

Screening Innovations:

• Automated hearing screeners reducing false positives

• Tele-audiology for remote follow-up diagnostics

• Current output supporting universal screening goals

---

3️⃣ 8. Bio-Rad Laboratories

Headquarters: Hercules, California, USA
Key Offering: Newborn screening kits, quality control reagents

Bio-Rad Laboratories provides essential test kits and controls for metabolic and endocrine screening, trusted by labs processing millions of samples yearly. Their products ensure consistency in detecting conditions like PKU and hypothyroidism. Bio-Rad’s expertise in assay development drives standardization across international screening networks.

Screening Innovations:

• Comprehensive QC materials for lab proficiency

• Multiplex assays for broader disorder coverage

• Collaborations for guideline-based panel expansion

---

2️⃣ 9. Medtronic Plc

Headquarters: Dublin, Ireland
Key Offering: Diagnostic devices, inherited screening solutions via Covidien legacy

Medtronic, through its Covidien portfolio, supports newborn screening with respiratory and monitoring devices used in NICUs. Their contributions to genetic service delivery include integrated systems for early intervention in congenital conditions. Medtronic’s global reach aids in scaling screening in hospitals worldwide.

Screening Innovations:

• Advanced ventilators with screening integration

• R&D in genetic-compatible monitoring

• Supply chain partnerships for device distribution

---

1️⃣ 10. PerkinElmer Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive newborn screening platforms, NGS-based genetic services

PerkinElmer (now Revvity) is the global leader in newborn screening, offering end-to-end solutions from sample collection to genetic confirmation. Their tandem MS and NGS services screen for dozens of disorders, serving public programs in over 100 countries. PerkinElmer’s innovations in high-throughput automation set the standard for preventive neonatal care.

Screening Innovations:

• Genome-wide NGS for rapid whole exome analysis

• Strategic alliances with health ministries worldwide

• Net-zero lab operations commitment by 2030

Read Full Report: Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Newborn Screening and Genetic Services Is Genomic and Accessible

The newborn screening and genetic services market is undergoing a profound transformation. While traditional biochemical tests remain core, the industry is investing heavily in NGS and AI-driven analytics, expanded panels, and point-of-care technologies to reach more infants globally.

📈 Key Trends Shaping the Market:

• Rapid NGS adoption in EU, US, and Asia-Pacific screening programs

• Regulatory expansions mandating 50+ disorders by 2030

• Digital platforms for data tracking and family counseling

• Public-private partnerships for equitable access

Read Full Report: Newborn Screening and Genetic Services Market – View in Detailed Research Report

The companies listed above are not only screening newborns—they’re spearheading the genomic revolution in preventive healthcare.